Rep. Kuster Statement on FDA Authorization of Pfizer-BioNTech's COVID-19 Vaccine for Children Age 5-11
October 30, 2021
October 30, 2021
CONCORD, New Hampshire, Oct. 30 -- Rep. Ann Kuster, D-New Hampshire, issued the following statement on Oct. 29, 2021:
* * *
Following the Food and Drug Administration's decision to extend the Emergency Use Authorization for Pfizer-BioNTech's COVID-19 vaccine to children aged 5 to 11, Rep. Annie Kuster (NH-02) released the following statement.
"COVID-19 vaccines are crucial to overcoming the pandemic, and today's FDA announcement that chi . . .
* * *
Following the Food and Drug Administration's decision to extend the Emergency Use Authorization for Pfizer-BioNTech's COVID-19 vaccine to children aged 5 to 11, Rep. Annie Kuster (NH-02) released the following statement.
"COVID-19 vaccines are crucial to overcoming the pandemic, and today's FDA announcement that chi . . .